From the Journals

Delays in cancer referral, diagnosis linked with morbidities


 

FROM FAMILY PRACTICE

Morbidities linked with emergency referral

The study also saw an association between morbidities and the likelihood of receiving an emergency referral. Those with three or more morbidities were 60% more likely to have an emergency referral than were those with no comorbidities. Those with a Charlson score of three or above were 61% more likely to be referred to an emergency department.

“The greater likelihood of clinical complexity or acute deterior­ation among individuals with multiple or severe chronic conditions means that an emergency referral may be clinically appropriate,” the authors wrote.

Commenting on the findings, Dr. Diane M. Harper, professor of family medicine at the University of Michigan, Ann Arbor, said primary care patients often have multiple chronic illnesses, and the relationship between the physician and patients determines how quickly symptoms of cancer are explored.

“What this work cannot explore is the quality of discussions between the physician and the patient, nor can it explore how the decision to go to the ED was made,” said Dr. Harper, president of the North American Primary Care Research Group. “Exploring these data would provide important information to the physician-patient dyad.”

Diagnostic difficulty might have been at play, according to authors

The investigators didn’t find any evidence of an interaction between cancer site, number of morbidities, and referral or diagnostic time, except in cases of colorectal cancer, where patients with multiple morbidities were more likely to experience a longer wait between primary care consultation and diagnosis.

The authors observed that diagnostic difficulty of the cancer might have been at play here, given that colorectal cancer can have a broad symptom signature.

“This was less often observed among patients diagnosed with a cancer that had a narrow symptom signature (“easy” diagnostic difficulty, e.g. breast cancer) or a broad symptom signature of mostly low PPVs (“hard” diagnostic difficulty, e.g. brain cancer),” they wrote.

The authors concluded that “it is reasonable to sug­gest that both improvement efforts and future research in this field should target patients with multiple or severe morbidity, and explore the reasons for prolonged diagnostic intervals in specialist care.”

The study was supported by Cancer Research UK. The authors and experts interviewed for this piece did not declare having any conflicts of interest.

Pages

Recommended Reading

FDA expands pembrolizumab approval for advanced melanoma
MDedge Hematology and Oncology
Metformin does not improve outcomes in early breast cancer
MDedge Hematology and Oncology
Vitamin D counters bone density loss with aromatase inhibitors
MDedge Hematology and Oncology
1 in 7 breast cancers are overdiagnosed
MDedge Hematology and Oncology
Ongoing HER2 breast cancer therapy may cost an additional $68,000 per patient
MDedge Hematology and Oncology
Genomic instability varies between breast cancer subtypes
MDedge Hematology and Oncology
Liver cancer risk lingers even after HCV eradication
MDedge Hematology and Oncology
Women struggle with benzodiazepine addiction post chemotherapy treatment
MDedge Hematology and Oncology
Omega-3 supplements may impact breast cancer risk
MDedge Hematology and Oncology
Antibiotic use associated with triple-negative breast cancer mortality
MDedge Hematology and Oncology